Detalhe da pesquisa
1.
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.
Lancet Oncol
; 22(6): 765-778, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33930323
2.
Immunogenicity of SARS-CoV-2 vaccines in patients with cancer.
Trends Mol Med
; 28(12): 1082-1099, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35999131
3.
Boosting of Waned Humoral and Cellular Responses to SARS-CoV-2 Variants of Concern Among Patients with Cancer.
Cancer Res Commun
; 2(11): 1449-1461, 2022 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36824220
4.
B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies.
Front Immunol
; 11: 622442, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33569063